13F filer · CIK 93751 ↗
State Street
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$1.10T
−16% on the quarter before
Positions
3,761
116 new · 125 sold out
Top 10
16.8%
of the value
Est. gain
−$182.13B
on stocks held all quarter
Est. return
−14.5%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from State Street's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$3.37BNew · 0.0% → 0.3%+21,625,224 shares
- Cigna Corp New~$3.08BNew · 0.0% → 0.3%+16,209,309 shares
- Cvs Health Corp~$1.10BAdded · 0.3% → 0.3%+16,729,536 shares
- Marathon Pete Corp~$696.4MAdded · 0.1% → 0.2%+11,801,124 shares
- Diamondback Energy Inc~$488.4MAdded · 0.0% → 0.1%+5,268,589 shares
- First Rep Bk San Francisco C~$315.5MAdded · 0.0% → 0.1%+3,630,516 shares
- AT&T~$278.6MAdded · 0.7% → 0.7%+9,761,387 shares
- Celanese Corp Del~$252.1MAdded · 0.0% → 0.0%+2,802,118 shares
- Alibaba~$240.4MAdded · 0.3% → 0.3%+1,754,098 shares
- Maxim Integrated Prods Inc~$226.3MAdded · 0.0% → 0.1%+4,450,082 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Aetna Inc~$3.86BSold out · 0.3% → 0.0%−19,034,113 shares
- Express Scripts Holding Co~$2.31BSold out · 0.2% → 0.0%−24,282,277 shares
- Cigna Corp~$2.13BSold out · 0.2% → 0.0%−10,206,994 shares
- Praxair Inc~$2.10BSold out · 0.2% → 0.0%−13,052,129 shares
- Apple~$1.12BCut · 3.3% → 2.7%−7,107,697 shares
- Andeavor~$1.10BSold out · 0.1% → 0.0%−7,189,924 shares
- Rockwell Collins Inc~$969.3MSold out · 0.1% → 0.0%−6,900,141 shares
- Nutrien Ltd~$631.9MCut · 0.1% → 0.0%−13,320,896 shares
- Ca Inc~$630.1MSold out · 0.0% → 0.0%−14,271,431 shares
- Jpmorgan Chase & Co~$616.5MCut · 1.4% → 1.3%−6,315,221 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.9% · price −11.2% | 2.8% | $30.84B | −$3.89B | ||||||||
| AppleCOM · shares −3.7% · price −30.1% | 2.7% | $29.25B | −$12.61B | ||||||||
| AmazonCOM · shares −0.5% · price −25.0% | 2.2% | $23.69B | −$7.90B | ||||||||
| Johnson & JohnsonCOM · shares −0.5% · price −6.6% | 1.8% | $19.57B | −$1.38B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −3.1% · price −4.6% | 1.5% | $16.10B | −$782.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares −4.0% · price −13.5% | 1.3% | $14.69B | −$2.29B | ||||||||
| Exxon Mobil CorpCOM · shares −2.6% · price −19.8% | 1.3% | $13.85B | −$3.42B | ||||||||
| Pfizer IncCOM · shares −0.1% · price −1.0% | 1.2% | $12.84B | −$123.6M | ||||||||
| Chevron Corp NewCOM · shares −0.06% · price −11.0% | 1.1% | $12.49B | −$1.55B | ||||||||
| Lockheed Martin CorpCOM · shares −1.6% · price −24.3% | 1.1% | $11.70B | −$3.76B | ||||||||
| MetaCL A · shares +1.1% · price −20.3% | 1.0% | $11.30B | −$2.85B | ||||||||
| AlphabetCAP STK CL C · shares −0.7% · price −13.2% | 1.0% | $11.27B | −$1.72B | ||||||||
| AlphabetCAP STK CL A · shares +1.3% · price −13.4% | 1.0% | $11.23B | −$1.72B | ||||||||
| Unitedhealth Group IncCOM · shares +1.1% · price −6.4% | 1.0% | $11.18B | −$751.2M | ||||||||
| Procter And Gamble CoCOM · shares +0.6% · price +10.4% | 0.94% | $10.31B | +$969.1M | ||||||||
| Visa Inc.COM CL A · shares −1.9% · price −12.1% | 0.92% | $10.05B | −$1.38B | ||||||||
| Bank Amer CorpCOM · shares −5.6% · price −16.4% | 0.88% | $9.65B | −$1.89B | ||||||||
| United Technologies CorpCOM · shares +2.2% · price −23.8% | 0.87% | $9.56B | −$2.93B | ||||||||
| IntelCOM · shares −1.6% · price −0.8% | 0.82% | $9.02B | −$69.2M | ||||||||
| Home Depot IncCOM · shares −3.3% · price −17.1% | 0.81% | $8.93B | −$1.84B | ||||||||
| Merck & Co IncCOM · shares −1.0% · price +8.5% | 0.78% | $8.59B | +$672.0M | ||||||||
| Verizon Communications IncCOM · shares +1.1% · price +5.3% | 0.78% | $8.56B | +$426.2M | ||||||||
| Wells Fargo Co NewCOM · shares −4.7% · price −12.3% | 0.77% | $8.44B | −$1.19B | ||||||||
| Boeing CoCOM · shares −1.6% · price −13.3% | 0.76% | $8.39B | −$1.29B | ||||||||
| CiscoCOM · shares −2.6% · price −10.9% | 0.75% | $8.27B | −$1.01B | ||||||||
| Total · 3,761 positions | 100% | $1.10T | −$182.13B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 3,644 stocks held throughout, down $182.13B (−14.5%).
- Procter And Gamble Co+$969.1M+10%
- Merck & Co Inc+$672.0M+8%
- Verizon Communications Inc+$426.2M+5%
- Mcdonalds Corp+$400.2M+6%
- Starbucks Corp+$394.9M+13%
- Nvidia−$3.44B−52%
- Lockheed Martin Corp−$3.76B−24%
- Microsoft−$3.89B−11%
- Amazon−$7.90B−25%
- Apple−$12.61B−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 10 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Sep 22, 2026 (amended) | $3.38T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.90T−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $2.98T+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.88T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.67T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $2.43T−4% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $2.53T+3% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.46T+7% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.29T+2% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.24T+9% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $2.06T+14% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $1.80T−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.90T+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $1.77T+4% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $1.70T+8% | SEC ↗ |
| Q3 2022 | Nov 15, 2022 | $1.58T−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.67T−17% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.02T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.11T+11% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $1.89T−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $1.90T+9% | SEC ↗ |
| Q1 2021 | Jul 9, 2021 (amended) | $1.74T+7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $1.63T+12% | SEC ↗ |
| Q3 2020 | Nov 10, 2020 | $1.46T+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $1.38T+20% | SEC ↗ |
| Q1 2020 | Jun 19, 2020 (amended) | $1.14T−22% | SEC ↗ |
| Q4 2019 | Feb 6, 2020 | $1.46T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 (amended) | $1.34T+0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.34T+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $1.28T+17% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $1.10T−16% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $1.30T+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $1.20T+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.18T−5% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.24T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.16T+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.13T+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.12T+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $1.06T+7% | SEC ↗ |
| Q3 2016 | Jan 13, 2017 (amended) | $992.21B+7% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $930.88B+1% | SEC ↗ |
| Q1 2016 | May 20, 2016 (amended) | $924.92B | SEC ↗ |